K31.A19

Clinical Causes: Helicobacter pylori infection Chronic gastritis Prolonged acid reflux Certain dietary factors, such as high salt intake and preserved foods Genetic predisposition Environmental factors, including smoking and alcohol consumption Previous stomach surgery or injury

Key Symptoms: Indigestion or a feeling of fullness Nausea or occasional vomiting Unexplained weight loss Loss of appetite Intermittent abdominal discomfort Bloating after meals No noticeable symptoms in some cases

Diagnosis Path: Diagnosis of gastric intestinal metaplasia typically involves procedures such as endoscopy, where a flexible tube with a camera is inserted into the stomach to visually assess the lining. During this examination, biopsy samples are taken from the stomach lining for histopathological analysis. Laboratory analysis confirms the presence of intestinal-type cells replacing normal stomach tissue without cellular abnormalities indicative of dysplasia. Additional testing may include testing for Helicobacter pylori infection, which is associated with tissue changes. Imaging studies are seldom necessary unless other gastric pathology is suspected.

Treatment Protocols: Management of gastric intestinal metaplasia focuses on monitoring and addressing underlying causes. Strategies may include the eradication of Helicobacter pylori infection using antibiotics, lifestyle modifications such as dietary changes, quitting smoking, and reducing alcohol intake. Regular follow-up endoscopies might be recommended to monitor for any progression or development of dysplasia or gastric cancer. In some cases, specific nutritional supplements or medications to reduce stomach acid may be prescribed. Importantly, early detection and ongoing surveillance are key to preventing potential progression to malignancy.